FDA Prosecution Criteria For “Responsible” Execs Includes Seriousness, Obviousness Of Violations
Almost a year after signaling its intent to target more individual executives with misdemeanor prosecutions when their companies have broken the law, FDA has published its criteria for pursuing such cases.
You may also be interested in...
Application of the Park doctrine to hold corporate officers strictly liable should depend upon an individual’s knowledge of wrongdoing committed under the Food, Drug and Cosmetic Act, Assistant U.S. Attorney for the District of Massachusetts Sara Bloom tells a compliance conference.
As penalties increase under responsible corporate officer doctrine, attorney Allison Burroughs, a partner at Nutter McClennen & Fish, says to expect increased scrutiny.
Marc Hermelin pleads guilty to distributing oversized morphine sulfate tablets; he may be first pharma exec to be jailed for healthcare fraud.